
Who are we? ChiraTecnics was founded in 2009 as a spin-out from the University of Évora, with the aim to manufacture and commercialise ligands, building blocks and catalysts for chiral synthesis. Whilst the company still offers this portfolio to clients, it now mainly focuses on custom synthesis programmes to support medicinal chemistry and drug discovery projects for pharmaceutical and biotech companies. It is led by a strong international team and has access to all vital equipment to implement our projects. |
News 2018年12月 我们很高兴地宣布,我们是2019年合成与催化国际研讨会(ISySyCat2019)的赞助商,并将参加这一激动人心的活动。 https://isysycat2019.eventos.chemistry.pt/
AUDEMARS PIGUET TRADITION REPLICA 2017年5月 第2届国际合成与催化会议(ISySyCat2017)将于2017年9月5日至8日在埃武拉大学举行。希望在那里见到你,我们将: http://isysycat2017.eventos.chemistry.pt/
2015年4月 我们与Évora大学签订了一项合同,将一些新型专利的最先进的手性有机催化剂商业化,这些有机催化剂用于高效的安全工艺(WO2015052656(A1)),以良好的产率和非常好的对映体控制手性胺。 。这些催化剂也可以固定化。
|
|
![]() |
![]() |
|
![]()
Did you Know?
The CRO Market for API and other chemicals is buzzing at the moment. Revenues in 2010 were $11.43 billion and it is estimated to reach $20.09 billion in 2020. Pharma is outsourcing more and more business to competent CROs. |
Our mission is to provide
|
|